Browsing by Author Moore, Malcolm

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Pavlakis, Nick; Simes, Robert John; Blondal, J; Burkes, R L; Gibbs, Peter; Jonker, D; Karapetis, Christos; Lee, U; Meharchand, J; Moore, Malcolm; O'Callaghan, Chris; Price, T.J.; Rubin, S; Shapiro, Jeremy; Tebbutt, Niall C; Tu, Dongsheng; van Hazel, Guy; Vickers, M; Zalcberg, John; Zhu, L; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreAssociation of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17, Annals of Oncology, vol.24, 4, 2013,pp 953-960
2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialClarke, Stephen; Cartwright, Thomas; Cunningham, David; De Gramont, A.; et al, Various; Hecht, J; Im, Seock-Ah; Moore, Malcolm; Rivera, Fernando; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, E; Concord Clinical School: MedicineBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial, Lancet Oncology, vol.13, 12, 2012,pp 1225-1233
2012Innovative training for rural medical studentsBennett, Paul; Bolte, Keryn; Moore, Malcolm; School of Rural Health: Broken Hill; School of Rural Health: Broken Hill; School of Rural Health: Broken HillInnovative training for rural medical students, The Clinical Teacher, vol.9, 4, 2012,pp 238-242
2014Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialShannon, Jenny; Campbell, Fiona; Costello, Eithne; Cox, Trevor; et al, Various; Garner, Elizabeth; Ghaneh, Paula; Greenhalf, William; Lamb, Richard; Mackey, John; Moore, Malcolm; Neoptolemos, John P.; Palmer, Daniel; Nepean Clinical School: MedicinePancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial, National Cancer Institute. Journal, vol.106, 1, 2014,pp 1-10
2013Patients' attitudes towards privacy in a Nepalese public hospital: a cross-sectional surveyMoore, Malcolm; Chaudhary, Ritesh; School of Rural Health: Broken HillPatients' attitudes towards privacy in a Nepalese public hospital: a cross-sectional survey, BMC Research Notes, vol.6, N/A, 2013,pp 1-5
2013Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 TrialSimes, Robert John; Zalcberg, John; Charpentier, Danielle; Couture, Felix; et al, Various; Jonker, Derek J.; Karapetis, Christos (Chris); Moore, Malcolm; Nott, Louise M; Price, Timothy; Shapiro, Jeremy; Siddiqui, Jehan; Siu, Lillian L; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePhase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial, Journal of Clinical Oncology, vol.31, 19, 2013,pp 2477-2484
2009Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 TrialSimes, Robert John; Tebbutt, Niall; Zalcberg, John; Au, Heather-Jane; Australasian Gastrointestinal Interest, Group; Colwell, Bruce; Evans, William K.; Findlay, Brian; Gibbs, Peter; Isogai, Pierre K.; Jonker, Derek J.; Karapetis, Christos; Links, Matthew; Mittman, Nicole; Moore, Malcolm; O'Callaghan, Chris; Siddiqui, Jehan; Tu, D.; Working Group on Economic Analysis of the National Cancer Institute of Canada, Clinical Trials Group; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreProspective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial, Journal of the National Cancer Institute, vol.101, 17, 2009,pp 1182-1192
2014Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialEl-Tahche, Fabyolla; Shannon, Jenny; Alcindor, Thierry; Au, Heather-Jane; Easaw, Jay C; et al, Various; Jeffery, Mark; Jonker, Derek J.; Kotb, Rami; Moore, Malcolm; Ng, Siobhan; Ringash, Jolie; Sabesan, Sabe; Salim, Muhammad; Shapiro, Jeremy; Siu, Lillian L; Strickland, A. H.; Zalcberg, John; Central Clinical School: Medicine; Nepean Clinical School: MedicineQuality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial, Cancer, vol.120, 2, 2014,pp 181-189
2011Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering ChemotherapyBeale, Philip; Butow, Phyllis; Clarke, Stephen; Goldstein, David; Horvath, Lisa; Shepherd, Heather; Tattersall, Martin; Wilcken, Nicholas; Chen, Eric; Feld, R; Hedley, David; Knox, Jennifer; Krzyzanowska, Monika; Leighl, Natasha B; McJannett, Margaret; Moore, Malcolm; Oza, Amit; Xu, Wei; Central Clinical School: Medicine; Psychology; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: Public Health; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy, Journal of Clinical Oncology, vol.29, 15, 2011,pp 2077-2084